Status:
COMPLETED
Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Neuromuscular Block, Residual
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring
Detailed Description
At the end of surgery, decide the dosage of reversal referring to quantitative neuromuscular monitoring value (TOF). After the administration of reversal, the anesthesiologist who are going to manage ...
Eligibility Criteria
Inclusion
- patients aged over 18 years, planned to undergoing elective laparoscopic surgery under general anesthesia
Exclusion
- Obesity BMI over 30 kg/m2
- Impairment of renal or/and liver function
- Allergy to rocuronium, sugammadex
- (Familial) history of malignant hyperthermia
- Taking medicines which is affecting neuromuscular function
Key Trial Info
Start Date :
September 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03292965
Start Date
September 28 2017
End Date
November 29 2017
Last Update
October 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620